[1] | Wang H, Gong C, Liu X, et al. Genetic interaction of purinergic P2X7 receptor and ER-α polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women. J Bone Miner Metab 2017 Sep 7. doi: 10.1007/s00774-017-0862-3. [Epub ahead of print] |
[2] | Antika LD, Lee EJ, Kim YH, etal. Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis. J Nutr Biochem 2017 Jul 28; 49: 42-52. |
[3] | Zhao XL, Chen JJ, Zhang GN, et al. Small molecule T63 suppresses osteoporosis by modulating osteoblast differentiation via BMP and WNT signaling pathways. Sci Rep 2017 Sep 4; 7 (1): 10397. doi: 10.1038/s41598-017-10929-3. |
[4] | Chen X, Zhi X, Cao L, et al. Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis. Cell Death Dis 2017 Sep 7; 8 (9): e3037. doi: 10.1038/cddis.2017.394. |
[5] | Löfdahl E, Rådegran G. Osteoporosis following heart transplantation and immunosuppressive therapy. Transplant Rev (Orlando) 2017 Aug 12. pii: S0955-470X(17)30039-3. doi: 10.1016/j.trre.2017.08.002. [Epub ahead of print] |
[6] | Kemp JP, Morris JA, Medina-Gomez C, et al. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nat Genet 2017 Sep 4. doi: 10.1038/ng.3949. [Epub ahead of print] |
[7] | Meier C, Uebelhart B, Aubry-Rozier B, et al. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss Med Wkly 2017 Sep 5; 147:w14484. doi: smw.2017.14484. eCollection 2017 Sep 5. |
[8] | Holick MF. Vitamin D deficiency. N Engl J Med 2007 Jul 19; 357 (3): 266-81. |
[9] | Kizilgul M, Kan S, Ozcelik O, et al. Vitamin D replacement improves tear osmolarity in patients with vitamin D deficiency. Semin Ophthalmol 2017 Sep 6: 1-6. doi: 10.1080/08820538.2017.1358752. [Epub ahead of print] |
[10] | Pilecka I, Sandin S, Reichenberg A, et al. Sun exposure and psychotic experiences. Front Psychiatry 2017 Jun 19; 8: 107. doi: 10.3389/fpsyt.2017.00107. eCollection 2017. |
[11] | Rolvien T, Krause M, Jeschke A, et al. Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone. Bone 2017 Jun 27; 103: 78-87. |
[12] | Iqbal AM, Dahl AR, Lteif A, et al. Vitamin D deficiency: A potential modifiable risk factor for cardiovascular disease in children with severe obesity. Children (Basel) 2017 Aug 28; 4 (9). pii: E80. doi: 10.3390/children4090080. |
[13] | Chen LW, Chien CY, Hsieh CW, et al. The associations between Helicobacter pylori infection, serum vitamin D, and metabolic syndrome: A Community-Based Study. Medicine (Baltimore) 2016 May; 95 (18): e3616. doi: 10.1097/MD.0000000000003616. |
[14] | Shih HM, Hsu TY, Chen CY, et al. Analysis of patients with Helicobacter pylori infection and the subsequent risk of developing osteoporosis after eradication therapy: A nationwide population-based cohort study. PLoS One 2016 Sep 14; 11 (9): e0162645. doi: 10.1371/journal.pone.0162645. eCollection 2016. |
[15] | Chung YH, Gwak JS, Hong SW, et al. Helicobacter pylori: A possible risk factor for bone health. Korean J Fam Med 2015 Sep; 36 (5): 239-44. |
[16] | Fotouk-Kiai M, Hoseini SR, Meftah N, et al. Relationship between Helicobacter pylori infection (HP) and bone mineral density (BMD) in elderly people. Caspian J Intern Med 2015 Spring; 6 (2): 62-6. |
[17] | Asaoka D, Nagahara A, Shimada Y, et al. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag 2015 Mar 6; 11: 381-91. |
[18] | Al Shaikh AM, Abaalkhail B, Soliman A, et al. Prevalence of vitamin D deficiency and calcium homeostasis in Saudi children. J Clin Res Pediatr Endocrinol 2016; 8 (4): 461-467. |
[19] | Kaddam IM, Al-Shaikh AM, Abaalkhail BA, et al. Prevalence of vitamin D deficiency and its associated factors in three regions of Saudi Arabia. Saudi Med J 2017; 38 (4): 381-390. |
[20] | Farinha P, Gascoyne RD. Helicobacter pylori and MALT Lymphoma. Gastroenterology 2005 May; 128 (6): 1579-605. |
[21] | Nasrat AM, Nasrat SAM, Nasrat RM, et al. Misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness. Gen Med 2015; S1 (002). [Open Access] |
[22] | Mizuno S, Matsui D, Watanabe I, et al. Serologically determined gastric mucosal condition Is a predictive factor for osteoporosis in Japanese men. Dig Dis Sci 2015 Jul; 60 (7): 2063-9. |
[23] | Lin SC, Koo M, Tsai KW. Association between Helicobacter pylori Infection and Risk of Osteoporosis in Elderly Taiwanese Women with Upper Gastrointestinal Diseases: A Retrospective Patient Record Review. Gastroenterol Res Pract 2014; 2014: 814756. doi: 10.1155/2014/814756. Epub 2014 May 13. |
[24] | Xu ZH, Zhang J, Yang D, et al. Progress of research between Helicobacter pylori infection and osteoporosis. Zhongguo Gu Shang 2011 Nov; 24 (11): 966-8. |
[25] | Suzuki H, Matsuzaki J, Hibi T. Lifestyle-related diseases and H. pylori. Nihon Rinsho 2009 Dec; 67 (12): 2366-71. |
[26] | Nasrat SAM, Randa MN, Nasrat MN, et al. The dramatic spread of diabetes mellitus worldwide and influence of Helicobacter pylori. General Med. 2015; 3 (1): 159-62. |
[27] | Bulut Y, Agacayak A, Karlidag D, et al. Association of CagA+ Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J Exp Med. 2006 Jul; 209 (3): 229-33. |
[28] | Nasrat AM, Nasrat RM, Nasrat MM. A pathologic etiology for the rising world challenge of obesity and dyslipidemia during latest three decades. Am J Med Med Sci 2017; 7 (8): 318-322. |
[29] | Chen Z, Xu C, Luo L, et al. Helicobacter pylori infection and gastric mucosa change and blood-lipid in people undergoing the physical examination in Changsha. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014 Mar; 39 (3): 265-9. |
[30] | Vijayvergiya R, Vadivelu R. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World J Cardiol 2015 Mar 26; 7 (3): 134-43. |
[31] | Buzás GM. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol 2014 May 14; 20 (18): 5226-34. |
[32] | Sharma V, Aggarwal A. Helicobacter pylori: Does it add to risk of coronary artery disease. World J Cardiol 2015 Jan 26; 7 (1): 19-25. |
[33] | Nasrat AM, Nasrat SAM, Nasrat RM, et al. The definitive eradication of Helicobacter pylori from the colon. Gen Med 2015; S1: 1. [Open Access] |
[34] | Nasrat RM, Nasrat MM, Nasrat AM, et al. Improvement of idiopathic cardiomyopathy after colon clear. J Cardiol Res 2015. [Open Access] |
[35] | Nasrat AM, Nasrat RM, Nasrat MM. Frequency of leukemia during late decades may indicate that the anti-Helicobacter pylori antibiotic strategy was a therapeutic mistake. Am J Med Med Sci 2017; 7 (3): 103-107. [Open Access] |
[36] | Hughes NJ, Clayton CL, Chalk PA, et al. Helicobacter pylori porCDAB oorDABC genes encode distinct pyruvate: flavodoxin and 2-oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADP. J Bacteriol 1998 Mar; 180(5): 1119-28. |
[37] | Berg JM, Tymoczko JL, Stryer L. Biochemistry. WH Freeman and Company. 2002; 5th Ed: 480. |
[38] | Mendz GL, Hazell SL. Fumarate catabolism in Helicobacter pylori. Biochem Mol Biol Int. 1993 Oct; 31 (2): 325-32. |
[39] | Mendz GL, Hazell SL, van Gorkom L. Pyruvate metabolism in Helicobacter pylori. Arch Microbiol. 1994; 162(3):187-92. |
[40] | Nasrat SAM, Randa MN, Nasrat MN, et al. The dramatic spread of diabetes mellitus worldwide and influence of Helicobacter pylori. General Med. 2015; 3 (1): 159-62. |
[41] | Bulut Y, Agacayak A, Karlidag D, et al. Association of CagA+ Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J Exp Med. 2006 Jul; 209 (3): 229-33. |
[42] | Nasrat AM. Biological benefits of Helicobacter pylori and the intelligence of juxta-mucosal ammonia. Am J Med Med Sci 2017; 7 (7): 281-286. [Open Access] |
[43] | Kubo N, Kochi S, Ariyama I, et al. Pseudomembranous colitis after Helicobacter pylori eradication therapy. Kansenshogaku Zasshi 2006 Jan; 80 (1): 51-5. |
[44] | Schweigart U, Franck H, Schepp W, et al. Toxic megacolon after Helicobacter pylori eradication therapy. Internist (Berl) 1997 Apr; 38 (4):352-4. |
[45] | Grünberger B, Wöhrer S, Streubel B, et al. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 2006 Mar 20; 24 (9):1370-5. |
[46] | Shah D, Gupta P. Vitamin D deficiency: Is the pandemic for real? Indian J Community Med 2015 Oct-Dec; 40 (4): 215-217. |
[47] | Posch PJ. Cholesterol does not cause coronary heart disease in contrast to stress. Scand Cardiovasc J 2008 Aug; 42 (4): 244-9. |
[48] | Rosch PJ. Saturated fat and cholesterol do not cause coronary heart disease. The Annual Conference of the Saudi Heart Association, Hofuf, Saudi Arabia, Oct 2008. Available from URL, www.sha.org.sa. |
[49] | Ravnskov U. The fallacies of the lipid hypothesis. Scand Cardiovasc J 2008 Aug; 42 (4): 236-9. |
[50] | Scherstén T, Rosch PJ, Arfors KE, et al. The cholesterol hypothesis: time for the obituary?. Scand Cardiovasc J 20011 Dec; 45 (6): 322-3. |
[51] | Midolo PD, Lambert JR, Hull R, et al. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol. 1995 Oct; 79(4); 475-9. |
[52] | Mendz GL, Ball GE, Meek DJ, Pyruvate metabolism in Campylobacter spp. Biochim Biophys Acta 1997 Mar 15; 1334 (2-3): 291-302. |
[53] | Mendz GL, Hazell SL, Burns BP. Glucose utilization and lactate production by Helicobacter pylori. J Gen Microbiol 1993 Dec; 139 (Pt 12): 3023-8. |
[54] | Asaka M. Epidemiology of Helicobacter pylori infection in Japan. Nippon Rinsho 2003 Jan; 61(1): 19-24. |
[55] | Nasrat AM. The world misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness. The 7th Anti-Aging Medicine World Congress, Monte-Carlo, Monaco, 2009 Mar. Available from URL, www.euromedicom.com. |